Victory Capital Management
IMA

Victory Capital Management’s ImageneBio Inc IMA Stock Holding History

Victory Capital Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,361
Closed -$1.41M – 2761
2021
Q4 		$1.41M Buy
9,361
+1,733
+23% +$281K ﹤0.01% 1680
2021
Q3 		$1.16M Sell
7,628
-54
-0.7% -$7.85K ﹤0.01% 1794
2021
Q2 		$1.29M Hold
7,682
– – ﹤0.01% 1801
2021
Q1 		$2.6M Buy
+7,682
New +$2.63M ﹤0.01% 1573

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Victory Capital Management's IMA Position: Q1 2022 in Review

Victory Capital Management sold out of ImageneBio Inc (IMA) in Q1 2022, closing a stake of 9,361 shares — an estimated $1.41M sold.

Victory Capital Management first reported a position in IMA in Q1 2021 and held it in 4 quarters. The position peaked at $2.6M in Q1 2021. 48 funds tracked by Wall St. Rank hold IMA as of Q1 2022.

  • Victory Capital Management reported no remaining ImageneBio Inc position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 9,361 ImageneBio Inc shares in Q1 2022, an estimated $1.41M.
  • Victory Capital Management first reported a position in ImageneBio Inc in Q1 2021 and held it in 4 quarters.
  • Victory Capital Management's ImageneBio Inc position peaked at $2.6M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.